Chad A. Witt
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Chad A. Witt has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- Derek Ernest Byers
Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, USA
2 shared publications - Aayusha Thapa
Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA
1 shared publication - Andrew E. Gelman
Department of Surgery, Division of Cardiothoracic Surgery, Washington University School of Medicine, St. Louis, United States of America
1 shared publication - Catherine Chen
Department of internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA
1 shared publication Cory T. Bernardt
Department of Pathology & Immunology, Washington University School of Medicine, St. Louis, Missouri, USA
1 shared publication- Daniel Kreisel
Department of Surgery, Division of Cardiothoracic Surgery, Washington University School of Medicine, St. Louis, MO, USA
1 shared publication
Latest Publications
- Open Access
- 12 March 2026
- Published by Elsevier in Seminars in Arthritis and Rheumatism
- Vol. 78, 152959
Trends and outcomes of lung transplant listings for connective tissue disease-associated interstitial lung disease (CTD-ILD): A 20-Year analysis from the organ procurement and transplantation network database
- 12 March 2026
- Published by Elsevier in Seminars in Arthritis and Rheumatism
- Vol. 78, 152959
Open AccessTrends and outcomes of lung transplant listings for connective tissue disease-associated interstitial lung disease (CTD-ILD): A 20-Year analysis from the organ procurement and transplantation network database
- Open Access
- 11 November 2025
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 136 (1)
Impaired complement regulation drives chronic lung allograft dysfunction after lung transplantation
A greater understanding of chronic lung allograft dysfunction (CLAD) pathobiology, the primary cause of death after lung transplantation (LTx), is needed to improve outcomes. The complement system links innate to adaptive immune responses and is activated early after lung transplantation to form C3 convertase, a critical enzyme that cleaves the central complement component C3. We hypothesized that LTx recipients with a genetic predisposition to enhanced complement activation have worse CLAD-free survival mediated through increased adaptive alloimmunity. We interrogated a known functional C3 polymorphism (C3 R102G) that increases complement activation through impaired C3 convertase inactivation in 2 independent LTx recipient cohorts. C3 R102G, identified in at least 1 of 3 LTx recipients, was associated with worse CLAD-free survival, particularly in the subset of recipients who developed donor-specific antibodies (DSAs). In a mouse orthotopic LTx model, impaired recipient complement regulation led to B cell–dependent CLAD pathology despite moderate differences in graft-infiltrating effector T cells. Dysfunctional complement regulation promoted intragraft accumulation of memory B cells and Ab-secreting cells, leading to increased local and circulating DSA levels in mice. In summary, genetic predisposition to complement activation is associated with an increased humoral response and worse CLAD-free survival.
- 11 November 2025
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 136 (1)
Open AccessImpaired complement regulation drives chronic lung allograft dysfunction after lung transplantation
A greater understanding of chronic lung allograft dysfunction (CLAD) pathobiology, the primary cause of death after lung transplantation (LTx), is needed to improve outcomes. The complement system links innate to adaptive immune responses and is activated early after lung transplantation to form C3 convertase, a critical enzyme that cleaves the central complement component C3. We hypothesized that LTx recipients with a genetic predisposition to enhanced complement activation have worse CLAD-free survival mediated through increased adaptive alloimmunity. We interrogated a known functional C3 polymorphism (C3 R102G) that increases complement activation through impaired C3 convertase inactivation in 2 independent LTx recipient cohorts. C3 R102G, identified in at least 1 of 3 LTx recipients, was associated with worse CLAD-free survival, particularly in the subset of recipients who developed donor-specific antibodies (DSAs). In a mouse orthotopic LTx model, impaired recipient complement regulation led to B cell–dependent CLAD pathology despite moderate differences in graft-infiltrating effector T cells. Dysfunctional complement regulation promoted intragraft accumulation of memory B cells and Ab-secreting cells, leading to increased local and circulating DSA levels in mice. In summary, genetic predisposition to complement activation is associated with an increased humoral response and worse CLAD-free survival.
- Open Access
- 23 September 2017
- Published by Elsevier in American Journal of Transplantation
- Vol. 18 (1) , 5-6
Voriconazole in lung transplant recipients – how worried should we be?
- 23 September 2017
- Published by Elsevier in American Journal of Transplantation
- Vol. 18 (1) , 5-6
Open AccessVoriconazole in lung transplant recipients – how worried should we be?